Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Emil Kakkis
AddedFeb 19, 2024
UpdatedMay 31, 2026
Emil Kakkis

Emil Kakkis

Board Member, Tarrant Venture Partners

CrunchbaseLinkedInThe Org

Emil Kakkis's Career

Tarrant Venture Partners
Tarrant Venture Partners

San Francisco, CA, US

Board Member· Board
Ultragenyx Pharmaceutical
Ultragenyx Pharmaceutical

Novato, CA, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Emil Kakkis's Career

Tarrant Venture Partners
Tarrant Venture Partners
Investment FirmInvestment Firm$800M51999San Francisco, CA, US
Board Member· Board

Leadership at Tarrant Venture Partners

William S. PriceWilliam S. PriceCo-Founder
Felicia GorcycaFelicia GorcycaBoard Member
Michael G. MacDougallMichael G. MacDougallBoard Member
James CoulterJames CoulterCo-Founder
Jon WinkelriedJon WinkelriedCEO
David BondermanDavid BondermanBoard Member

Similar to Tarrant Venture Partners

Top Tier Capital PartnersTop Tier Capital PartnersSan Francisco, CA, USest. 1999Top Tier Capital PartnersSan Francisco, CA, US · est. 1999

TTCP: A venture capital specialist creating diverse portfolios, investing in emerging trends.

Investment Firm75
Watertower VenturesWatertower VenturesLos Angeles, CA, USest. 2017Watertower VenturesLos Angeles, CA, US · est. 2017

Watertower Ventures: A seed and early-stage venture capital fund, providing initial capital for founders.

Investment Firm11
Trinity VenturesTrinity VenturesMenlo Park, CA, USest. 1986Trinity VenturesMenlo Park, CA, US · est. 1986

Trinity Ventures: A leading venture capital firm, expertly guiding startups to significant success.

Investment Firm38
Tiller PartnersTiller PartnersLos Angeles, CA, USest. 2012Tiller PartnersLos Angeles, CA, US · est. 2012

Tamarisk Global, LLC: A US-based venture capital firm specializing in early and late-stage investments.

Investment Firm4
Ultragenyx Pharmaceutical
Ultragenyx Pharmaceutical
Public$789.3M1.3k2010Novato, CA, US
Board Member· Board

Leadership at Ultragenyx Pharmaceutical

Clay SiegallClay SiegallBoard Member
Amrit RayAmrit RayBoard Member
Matthew FustMatthew FustBoard Member
Deborah DunsireDeborah DunsireBoard Member
Marten SteenMarten SteenBoard Member
Shehnaaz SulimanShehnaaz SulimanBoard Member

Similar to Ultragenyx Pharmaceutical

PTC TherapeuticsPTC TherapeuticsSouth Plainfield, NJ, USPharmaceuticalsest. 1998PTC TherapeuticsSouth Plainfield, NJ, US · est. 1998

PTC Therapeutics, Inc.: A US-based pharmaceutical company specializing in oral, small-molecule drugs for genetic disorders, oncology, and infectious diseases.

Public · $1.6B1.4k
Ionis PharmaceuticalsIonis PharmaceuticalsCarlsbad, CA, USPharmaceuticalsest. 1989Ionis PharmaceuticalsCarlsbad, CA, US · est. 1989

Ionis Pharmaceuticals: A US-based biotech firm specializing in RNA-targeted drug discovery for unmet needs.

Public · $1.3B796
Amicus TherapeuticsAmicus TherapeuticsCranbury, NJ, USBiopharmaceuticalsest. 2002Amicus TherapeuticsCranbury, NJ, US · est. 2002

Amicus Therapeutics, a US-based public biopharmaceutical company, specializes in innovative medical solutions.

Public · $2.4B484
Amylyx PharmaceuticalsAmylyx PharmaceuticalsCambridge, MA, USTherapeuticsest. 2014Amylyx PharmaceuticalsCambridge, MA, US · est. 2014

Amylyx Pharmaceuticals: A global biopharmaceutical firm innovating therapies for ALS and neurodegenerative diseases.

Public · $448.5M262

Emil Kakkis's Similar Executives & Operators

Nugroho HerucahyonoNugroho HerucahyonoCo-Founder · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakWillix HalimWillix HalimCEO · BukalapakAchmad ZakyAchmad ZakyCo-Founder · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakChi-hyung SongChi-hyung SongBoard Member · DunamuHaeil YiHaeil YiCo-Founder · Dunamu

People Similar to Emil Kakkis

Jay ShendureJay ShendureBoard Member · Adaptive BiotechnologiesAndrew HesselAndrew HesselBoard Member · Singularity UniversityDietrich StephanDietrich StephanFounder & CEO · LifeXSusan SmalleySusan SmalleyCo-Founder · PTK GlobalChristopher MasonChristopher MasonCo-Founder · BiotiaSpencer WellsSpencer WellsCo-Founder · Insitome